GLAXOSMITHKLINE PLC Transaction History

Date Transaction Value Shares Traded Form
May 20 2021
SELL
Open market or private sale
$392,064,435 $12.25 p/Share
32,005,260

Also insider at

CRSP
CRISPR Therapeutics AG Healthcare
SPRO
Spero Therapeutics, Inc. Healthcare
TBIO
Translate Bio, Inc. Healthcare
LQDA
Liquidia Technologies Inc
PRNB
Principia Biopharma Inc.
CCXI
ChemoCentryx, Inc.
TPTX
Turning Point Therapeutics, Inc.
BCYC
BICYCLE THERAPEUTICS plc Healthcare
GNCA
GENOCEA BIOSCIENCES, INC. Healthcare
MORF
Morphic Holding, Inc. Healthcare
FULC
Fulcrum Therapeutics, Inc. Healthcare
PGNY
Progyny, Inc. Healthcare
NKTX
Nkarta, Inc. Healthcare
PAND
Pandion Therapeutics, Inc.
DBTX
Decibel Therapeutics, Inc. Healthcare
LYEL
Lyell Immunopharma, Inc. Healthcare
CVRX
CVRx, Inc. Healthcare
TBPH
Theravance Biopharma, Inc. Healthcare
WVE
Wave Life Sciences Ltd. Healthcare
GP

Glaxosmithkline PLC

> 10% Shareholder
Brentford Middlesex, X0

Track Institutional and Insider Activities on INVA

Follow Innoviva, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells INVA shares.

Notify only if

Insider Trading

Get notified when an Innoviva, Inc. insider buys or sells INVA shares.

Notify only if

News

Receive news related to Innoviva, Inc.

Track Activities on INVA